FORA Capital’s Cardlytics CDLX Stock Holding History

FORA Capital’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-113	Closed	-$124K	–	902
2021 Q1	$124K	Sell	113 -250	-69%	-$330K	0.04%	373
2020 Q4	$518K	Buy	+363	New	+$387K	0.08%	273
2020 Q3	–	Sell	-114	Closed	-$80K	–	689
2020 Q2	$80K	Sell	114 -1,676	-94%	-$968K	0.03%	549
2020 Q1	$626K	Buy	1,790 +1,640	+1,093%	+$1.16M	0.14%	195
2019 Q4	$94K	Buy	+150	New	+$73.3K	0.01%	758

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

FORA Capital's CDLX Position: Q2 2021 in Review

FORA Capital sold out of Cardlytics (CDLX) in Q2 2021, closing a stake of 113 shares — an estimated $124K sold.

FORA Capital first reported a position in CDLX in Q4 2019 and held it in 5 quarters. The position peaked at $626K in Q1 2020. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.

FORA Capital reported no remaining Cardlytics position as of Q2 2021 after selling out during the quarter.
FORA Capital sold 113 Cardlytics shares in Q2 2021, an estimated $124K.
FORA Capital first reported a position in Cardlytics in Q4 2019 and held it in 5 quarters.
FORA Capital's Cardlytics position peaked at $626K in Q1 2020.
189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.

Based on FORA Capital's 13F filing for Q2 2021, filed 16 Aug 2021.